Pacira Pharmaceuticals (PCRX) PT Raised to $48 at H.C. Wainwright
Tweet
Share
E-mail
Get Alerts PCRX Hot Sheet
Price: $26.49 +0.08%
Rating Summary:
12 Buy, 15 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 31
Rating Summary:
12 Buy, 15 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 31
Join SI Premium – FREE
H.C. Wainwright raised its price target on Pacira Pharmaceuticals (NASDAQ: PCRX) to $48.00 (from $45.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Braze Inc (BRZE) PT Raised to $40 at DA Davidson
- Credo Tech (CRDO) PT Lowered to $310 at JPMorgan, Overweight Rating Maintained
- MongoDB (MDB) PT Raised to $470; Piper Sandler: 'We would be buyers of the pullback in shares'
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
H.C. WainwrightSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
